{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:34:14Z","timestamp":1788348854187,"version":"build-2803163510"},"reference-count":18,"publisher":"Center for Academic Publications Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2019,4,30]]},"DOI":"10.3177\/jnsv.65.202","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T22:51:20Z","timestamp":1556578280000},"page":"202-204","source":"Crossref","is-referenced-by-count":18,"title":["Rubiscolin-6, a \u03b4-Opioid Peptide from Spinach RuBisCO, Exerts Antidepressant-Like Effect in Restraint-Stressed Mice"],"prefix":"10.3177","volume":"65","author":[{"given":"Yasuhide","family":"MITSUMOTO","sequence":"first","affiliation":[{"name":"Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"SATO","sequence":"additional","affiliation":[{"name":"Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"TAGAWA","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"KATO","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Kobe Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Yoshikawa M. 2015. Bioactive peptides derived from natural proteins with respect to diversity of their receptors and physiological effects. Peptides 72: 208-225.","DOI":"10.1016\/j.peptides.2015.07.013"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yokota A. 2017. Revisiting RuBisCO. Biosci Biotechnol Biochem 81: 2039-2049.","DOI":"10.1080\/09168451.2017.1379350"},{"key":"3","unstructured":"3) Yang S, Yunden J, Sonoda S, Doyama N, Lipkowski AW, Kawamura Y, Yoshikawa M. 2001. Rubiscolin, a delta selective opioid peptide derived from plant Rubisco. FEBS Lett 509: 213-217."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Perlikowska R, Janecka A. 2018. Rubiscolins\u2014Highly potent peptides derived from plant proteins. Mini Rev Med Chem 18: 104-112.","DOI":"10.2174\/1389557517666170426160703"},{"key":"5","unstructured":"5) Yang S, Kawamura Y, Yoshikawa M. 2003. Effect of rubiscolin, a delta opioid peptide derived from Rubisco, on memory consolidation. Peptides 24: 325-328."},{"key":"6","unstructured":"6) Hirata H, Sonoda S, Agui S, Yoshida M, Ohinata K, Yoshikawa M. 2007. Rubiscolin-6, a delta opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating \u03c3<sub>1<\/sub> and dopamine D<sub>1<\/sub> receptors. Peptides 28: 1998-2003."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. 2002. Behavioral effects of delta-opioid receptor agonists: potential antidepressants? Jpn J Pharmacol 90: 1-6.","DOI":"10.1254\/jjp.90.1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Saitoh A, Yamada M. 2012. Antidepressant-like effects of \u03b4 opioid receptor agonists in animal models. Curr Neuropharmacol 10: 231-238.","DOI":"10.2174\/157015912803217314"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Cryan JF, Mombereau C, Vassout A. 2005. The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci Behav Rev 29: 571-625.","DOI":"10.1016\/j.neubiorev.2005.03.009"},{"key":"10","unstructured":"10) Poleszak E, Wlaz P, Kedzierska E, Nieoczym D, Wyska E, Szymura-Oleksiak J, Fidecka S, Radziwon-Zaleska M, Nowak G. 2006. Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol Rep 58: 746-752."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85: 367-370.","DOI":"10.1007\/BF00428203"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mori A, Okuyama K, Horie M, Taniguchi Y, Wadatsu T, Nishino N, Shimada Y, Miyazawa N, Takeda S, Niimi M, Kyushiki H, Kondo M, Mitsumoto Y. 2002. Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice. Neurosci Res 43: 251-257.","DOI":"10.1016\/S0168-0102(02)00041-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mori A, Ohashi S, Nakai M, Moriizumi T, Mitsumoto Y. 2005. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice. Neurosci Res 51: 265-274.","DOI":"10.1016\/j.neures.2004.11.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Martins J, S B. 2018. Phytochemistry and pharmacology of anti-depressant medicinal plants: A review. Biomed Pharmacother 104: 343-365.","DOI":"10.1016\/j.biopha.2018.05.044"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 609-622.","DOI":"10.1176\/ajp.122.5.509"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Pradhan AA, Befort K, Nozaki C, Gav\u00e9riaux-Ruff C, Kieffer BL. 2011. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32: 581-590.","DOI":"10.1016\/j.tips.2011.06.008"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Song C, Leonard BE. 2005. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29: 627-647.","DOI":"10.1016\/j.neubiorev.2005.03.010"},{"key":"18","unstructured":"18) Saitoh A, Yamada M, Takahashi K, Yamaguchi K, Murasawa H, Nakatani A, Tatsumi Y, Hirose N, Kamei J. 2008. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ((+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl] -N,N-diethylbenzamide) in an olfactory bulbectomized rat model. Brain Res 1208: 160-169."}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/65\/2\/65_202\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T03:42:54Z","timestamp":1556941374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/65\/2\/65_202\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,30]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.65.202","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"value":"0301-4800","type":"print"},{"value":"1881-7742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,30]]}}}